Lilly to buy Adverum Biotechnologies
The acquisition strengthens Lilly’s genetic medicine pipeline and expands its footprint in ophthalmology.
The acquisition strengthens Lilly’s genetic medicine pipeline and expands its footprint in ophthalmology.